Where the Passion Begins
Mark Jewell, PhD
Mark has focused his career within the life science industry and with managed care providers developing population-based predictive models to identify patients at risk for significant events. Early in his career, his work was integral to the development and implementation of the Clinical Quality Improvement Program at Advocate Health System. Before joining EPI-Q, Mark served as a consultant to the Institute for Cultural Affairs in developing HIV testing strategies in developing nations and has chaired professional organizations and task forces related to health improvement initiatives. Mark received his MS in Public Health from the University of Illinois and a PhD in Health Services and Epidemiology from Walden University. He holds faculty positions at the University of Illinois College of Pharmacy and School of Public Health.
Alicia Shillington, PhD
Alicia provides expertise in quantitative methods in measuring clinical and economic outcomes associated with health care delivery and health program implementation. With nearly 25 years’ experience in clinical, epidemiologic, pharmacoeconomic, and outcomes research, her clinical research focus has included oncology, vascular surgery, metabolic disease, asthma, allergy and immunology, cardiology, cardiopulmonary medicine, and infectious disease. Before joining EPI-Q in 1994, she spent 10 years developing the Epidemiology and Outcomes Research function within Advocate Health Care. Alicia holds a PhD in Public Health Sciences, Health Policy/Health Services Research, and an MPH in Epidemiology and Biostatistics from the University of Illinois at Chicago. She also holds a Bachelor of Science in Nursing from Valparaiso University in Indiana.
Katie Deering, PharmD
Katie has worked in health-system pharmacies and working in Health Economics and Outcomes Research for over 10 years. Before joining EPI-Q, she served as the Nephrology/Internal Medicine Clinical Specialist for Saint Joseph Mercy Hospital in Ann Arbor, Michigan. She also is adjunctive faculty for five schools of pharmacy and past-president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Chicago Chapter. She holds a PharmD from the University of Missouri-Kansas City School of Pharmacy and completed an ASHP-accredited Pharmacy Practice Residency at Saint Luke’s Hospital in Kansas City, Missouri.
Qing Harshaw, MD, PhD
Qing joined EPI-Q in 2003 and has more than 20 years’ experience in health services research. Her work includes health policy research, econometric modeling, outcomes and clinical effectiveness research, as well as retrospective database analysis. She previously served as a postdoctoral fellow at the Center for Outcomes Research, Effectiveness, and Education at the University of Alabama and as a consultant to The World Bank’s Economic Development Institute. She received her MS in Biostatistics and MD degrees from Beijing Medical University and served as Deputy Chair of their Department of Health Economics. She holds an MA in Population Studies from the University of Exeter and received a PhD in Administration Health Services from the University of Alabama at Birmingham.
Dolly Sharma, PhD
Dolly is a Health, Economics and Outcomes researcher with experience in strategically planning and executing cost-effectiveness, retrospective observational (using claims, national sales and hospital databases), prospective, and survey-based studies, to evaluate the value of drugs, devices and examine the impact of policies. Dr Sharma completed her doctorate degree in Pharmaco-economics form University of Illinois at Chicago. Prior to her PhD, Dr Sharma was involved in conducting large systematic reviews for HTA submissions for Pharma clients. She also has Bachelor’s and Master’s degrees in Pharmacy from Delhi Institute of Pharmaceutical Sciences and Research, India.